Primary Record
Compound E
- In stock
- 5,304 g
- Purity
- 99.2 %
- CAS
- 209986-17-4
Compound Identifiers & Properties
- CAS
- 209986-17-4
- PubChem CID
- 11306390
- SMILES
- C[C@@H](C(=O)N[C@@H]1C(=O)N(C2=CC=CC=C2C(=N1)C3=CC=CC=C3)C)NC(=O)CC4=CC(=CC(=C4)F)F
- Canonical SMILES
- C[C@H](NC(=O)Cc1cc(F)cc(F)c1)C(=O)N[C@H]1N=C(c2ccccc2)c2ccccc2N(C)C1=O
Names & Synonyms
- Compound E
- gamma-Secretase Inhibitor XXI
- CompoundE
- GSI-XXI
- 209986-17-4
- Gamma-secretase inhibitor
- |A-Secretase Inhibitor XXI
- RefChem:127655
- A1D6X
- SCHEMBL453584
- C27H24F2N4O3
- CHEBI:101713
- orb1694781
- W6YYB9B856
- CHEMBL1091498
- DTXSID0042666
- SCHEMBL29359226
- CTK8F8764
- Compound E (secretase inhibitor)
- CHEBI:131161
- GLXC-02107
- EX-A3838
- HB3849
- ZB1617
- ZINC22309215
- AKOS037435223
- CID11306390
- Compound E (?-Secretase Inhibitor XXI)
- BS-15830
- CID 11306390
- CID:11306390
- FD103782
- HY-14176
- gamma-Secretase Inhibitor XXI, Compound E
- SID:321941736
- CS-0003250
- J1.811.585I
- E98743
- C576532
- (S)-2-(2-(3,5-difluorophenyl)acetamido)-N-((S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)propanamide
- A1007461
- COMPOUND E ((2S)-2-(AMINO)-N-PROPANAMIDE)
- (2S)-2-[[2-(3,5-difluorophenyl)acetyl]amino]-N-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]propanamide
- (S,S)- 2-[2-(3,5-Difluorophenyl)-acetylamino]-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-propionamide
- (s,s)-2-[2-(3,5-difluorophenyl)-acetylamino]-n-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1h-benzo[e][1,4]diazepin-3-yl)-propionamide
- N(2)-[(3,5-difluorophenyl)acetyl]-N-[(3S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]-L-alaninamide
- N-[(1S)-2-[[(3S)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]amino]-1-methyl-2-oxoethyl]-3,5-difluorobenzeneacetamide
- (2S)-2-[2-(3,5-difluorophenyl)acetamido]-N-[(3S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]propanamide
- (2S)-2-[2-(3,5-difluorophenyl)acetamido]-N-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]propanamide
- 1,3-Dihydro-3beta-[[(S)-2-[(3,5-difluorophenyl)acetylamino]propionyl]amino]-1-methyl-5-phenyl-2H-1,4-benzodiazepine-2-one
- 2-(2-(3,5-difluorophenyl)-acetylamino)-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo(e)(1,4)diazepin-3-yl)propionamide
- Benzeneacetamide, N-[(1S)-2-[[(3S)-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]amino]-1-methyl-2-oxoethyl]-3,5-difluoro-
- N(2)-((3,5-difluorophenyl)acetyl)-N-((3S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl)-L-alaninamide
- N-[(1S)-2-[[(3S)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]amino]-1-methyl-2-oxoethyl]-3,5-difluorobenzeneacetam ide
- N-[(3S)-1-Methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepine-3beta-yl]-Nalpha-(alpha-oxo-3,5-difluorophenethyl)-L-alaninamide
- N~2~-[(3,5-Difluorophenyl)acetyl]-N-[(3S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]-L-alaninamide